TY - JOUR
T1 - Serum cytokine profile in patients with chronic rhinosinusitis with nasal polyposis infected by aspergillus flavus
AU - Rai, Gargi
AU - Ansari, Mohammad Ahmad
AU - Dar, Sajad Ahmad
AU - Datt, Shyama
AU - Gupta, Neelima
AU - Sharma, Sonal
AU - Haque, Shafiul
AU - Ramachandran, Vishnampettai Ganapathysubramanian
AU - Mazumdar, Arpeeta
AU - Rudramurthy, Shivprakash
AU - Chakrabarti, Arunaloke
AU - Das, Shukla
PY - 2018
Y1 - 2018
N2 - Background: Fungi, especially Aspergillus flavus, can cause chronic rhinosinusitis with nasal polyposis and modulate host innate immune components. The objective of this study was to examine the serum levels of T helper (Th) cell subset Th1, Th2, and Th17 cytokines and total IgE in patients having chronic rhinosinusitis with nasal polyposis and Aspergillus flavus infection. Methods: A case-control study including 40 patients with chronic rhinosinusitis with nasal polyposis and 20 healthy controls was conducted. Aspergillus flavus infection was confirmed by standard potassium hydroxide (KOH) testing, culture, and PCR. Serum samples of all patients and controls were analyzed for various cytokines (interleukins [IL]-1β, IL-2, IL-4, IL-6, IL-17, IL-21, IL-27, TGF-β) and total IgE by ELISA. Data from patients with Aspergillus flavus infection and healthy volunteers were compared using the independent t-Test and non-parametric Mann-Whitney U test. Results: Aspergillus flavus infection was found in 31 (77.5%) patients with chronic rhino-sinusitis with nasal polyposis. IL-1β, IL-17, IL-21, and TGF-β serum levels were signifi-cantly higher in these patients than in controls; however, IL-2, IL-4, IL-6, and IL-27 levels were lower. Compared with nine (22.5%) patients without Aspergillus flavus infection, IL-17 level was higher while IL-2 level was lower in patients with Aspergillus flavus infection. Total IgE was significantly higher in patients with Aspergillus flavus infection than in controls. Conclusions: High levels of IL-17 and its regulatory cytokines in patients with chronic rhinosinusitis with nasal polyposis infected by Aspergillus flavus raise a concern about effective disease management and therapeutic recovery. Surgical removal of the nasal polyp being the chief management option, the choice of post-operative drugs may differ in eosinophilic vs. non-eosinophilic nasal polyposis. The prognosis is likely poor, warranting extended care.
AB - Background: Fungi, especially Aspergillus flavus, can cause chronic rhinosinusitis with nasal polyposis and modulate host innate immune components. The objective of this study was to examine the serum levels of T helper (Th) cell subset Th1, Th2, and Th17 cytokines and total IgE in patients having chronic rhinosinusitis with nasal polyposis and Aspergillus flavus infection. Methods: A case-control study including 40 patients with chronic rhinosinusitis with nasal polyposis and 20 healthy controls was conducted. Aspergillus flavus infection was confirmed by standard potassium hydroxide (KOH) testing, culture, and PCR. Serum samples of all patients and controls were analyzed for various cytokines (interleukins [IL]-1β, IL-2, IL-4, IL-6, IL-17, IL-21, IL-27, TGF-β) and total IgE by ELISA. Data from patients with Aspergillus flavus infection and healthy volunteers were compared using the independent t-Test and non-parametric Mann-Whitney U test. Results: Aspergillus flavus infection was found in 31 (77.5%) patients with chronic rhino-sinusitis with nasal polyposis. IL-1β, IL-17, IL-21, and TGF-β serum levels were signifi-cantly higher in these patients than in controls; however, IL-2, IL-4, IL-6, and IL-27 levels were lower. Compared with nine (22.5%) patients without Aspergillus flavus infection, IL-17 level was higher while IL-2 level was lower in patients with Aspergillus flavus infection. Total IgE was significantly higher in patients with Aspergillus flavus infection than in controls. Conclusions: High levels of IL-17 and its regulatory cytokines in patients with chronic rhinosinusitis with nasal polyposis infected by Aspergillus flavus raise a concern about effective disease management and therapeutic recovery. Surgical removal of the nasal polyp being the chief management option, the choice of post-operative drugs may differ in eosinophilic vs. non-eosinophilic nasal polyposis. The prognosis is likely poor, warranting extended care.
KW - Aspergillus flavus
KW - Chronic rhinosinusitis
KW - Cytokines
KW - Nasal polyposis
UR - https://www.scopus.com/pages/publications/85040223791
U2 - 10.3343/alm.2018.38.2.125
DO - 10.3343/alm.2018.38.2.125
M3 - Artículo
C2 - 29214756
AN - SCOPUS:85040223791
SN - 2234-3806
VL - 38
SP - 125
EP - 131
JO - Annals of Laboratory Medicine
JF - Annals of Laboratory Medicine
IS - 2
ER -